Niacin Beats Ezetimibe Head to Head

December 2009
Internal Medicine Alert;12/15/2009 Pharmacology Watch, p1
The article presents a study which examines the impact of statin and niacin on the level of high-density lipoprotein-cholesterol (HDL-C).


Related Articles

  • Over-the-Counter Niacin Preparations for Dyslipidemia. Sadovsky, Richard // American Family Physician;9/1/2004, Vol. 70 Issue 5, p956 

    Provides information on over-the-counter niacin preparations for dyslipidemia. Use of nicotinic acid; Information on the Coronary Drug Project; Result of nicotinic acid therapy when combined with a bileacid sequestrant or a statin.

  • Do patients on statins also need niacin? Jones, Kelly W. // JAAPA: Journal of the American Academy of Physician Assistants (;Jul2013, Vol. 26 Issue 7, p9 

    Niacin has been used for years to treat hypercholesterolemia, but may not be as beneficial as thought for patients at high risk of cardiovascular disease. Until further research is done, niacin should be used only in patients who do not tolerate or respond to statin therapy, and never in...

  • Don't Do This Alone. Harrar, Sari; Doherty, Bridget // Prevention;Jun2002, Vol. 54 Issue 6, p48 

    Advises taking precautions before using a cholesterol-lowering statin drug plus the B vitamin niacin, a therapy to reduce heart attacks and strokes.

  • Lipid-lowering therapies: New uses, combo regimens profiled at heart meeting.  // Pharmacy Today;Dec2004, Vol. 10 Issue 12, p6 

    This article focuses on lipid-lowering therapies. From statins to niacin to vitamin E, the data were plentiful in New Orleans when the American Heart Association convened for its Scientific Sessions 2004. In addition to supporting more aggressive treatments for patients with dyslipidemias,...

  • If You're Already on a Statin, Does Adding Niacin Help?  // Neurology Alert;Feb2012 Clinical Brief, p1 

    The article discusses research on the effects of taking niacin as an additional medication in preventing the recurrence of cardiovascular events in patients under statin medication, referencing a study published in a 2011 issue of "The New England Journal of Medicine."

  • Life after statin patent expiries. Kidd, Jane // Nature Reviews Drug Discovery;Oct2006, Vol. 5 Issue 10, p813 

    The article offers news briefs related to statins. Statins differ in potency, but many patients require LDL reductions of only 30–40%, which is achievable with all statins. Before the statins became the treatment of choice for high cholesterol, the hypolipidaemics were used routinely,...

  • Comprehensive lipid management now possible.  // British Journal of Hospital Medicine (17508460);Sep2009, Vol. 70 Issue 9, p496 

    The article investigates the effectiveness of tredative in treating dyslipidaemia. It features the pharmacologic ingredients of tredative including laropiprant and nicotinic acid. In addition, it is considered as more effective in lipid management compared to statin monotherapy. It cites that...

  • Complementarity of Colestipol, Niacin, and Lovaststin in Treatment of Severe Familial Hypercholesterolemia.  // Annals of Internal Medicine;Nov87, Vol. 107 Issue 5, p618 

    Provides information on a study which examined the therapeutic effect of colestipol, niacin and lovastatin on hypercholesterolemia. Plasma content of apolipoproteins; Side effects of the triple-drug regimen; Discussion.

  • Taking lipid-lowering drugs.  // Patient Care;10/15/2001, Vol. 35 Issue 19, p56 

    Provides information on different lipid-lowering drugs to prevent cardiovascular disease. Recommended dosage of resins; Discussion on statins; Physiological effects of niacin.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics